Scholar Rock Holding Corporation announced that Yung Chyung, M.D. has decided to step down as Chief Medical Officer (CMO) to explore new career opportunities, including his interest in global health, effective June 30, 2022. Dr. Chyung will remain with Scholar Rock to work with the executive team and the development organization on a transition plan, and a retained search for a new CMO is ongoing.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.3 USD | -3.42% | -16.46% | -45.48% |
23/05 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
22/05 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.48% | 85Cr | |
+9.81% | 12TCr | |
+10.09% | 11TCr | |
-11.88% | 2.34TCr | |
-1.69% | 2.21TCr | |
-10.23% | 1.83TCr | |
-41.92% | 1.66TCr | |
-15.67% | 1.6TCr | |
+6.18% | 1.4TCr | |
+14.88% | 1.17TCr |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Yung Chyung, M.D. Decides to Step Down as Chief Medical Officer of Scholar Rock Holding Corporation, Effective June 30, 2022